Search Results - "Dagorne, Anaig"
-
1
Extensive bone marrow necrosis and sickle cell disease
Published in Annales de biologie clinique (Paris) (01-09-2013)“…A 24-years old Gabonese women with sickle cell disease had a severe vaso-occlusive crisis, which was treated by exchange transfusion. Then, she developed an…”
Get more information
Journal Article -
2
Myelodysplatic Syndrom
Published in Blood (19-11-2010)“…Abstract 4980 Myelodysplastic syndrome of 5q- type is generally considered to have a favorable course. But, even in the Lenalidomide era, it has been evidenced…”
Get full text
Journal Article -
3
Post-ASCT Consolidative Immunotherapy with RITUXIMAB, rINF-a2b and rIL2 In Poor-Risk DLBCL: Results of a Phase II Study
Published in Blood (19-11-2010)“…Abstract 3558 A minority of patients with diffuse large B cell lymphoma (DLBCL) can really be cured and the early or late relapse rate remains a subject of…”
Get full text
Journal Article -
4
Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase
Published in Leukemia & lymphoma (02-12-2018)“…Myeloproliferative neoplasms (MPN) are chronic disorders that can sometimes evolve into accelerated or leukemic phases. We retrospectively identified 122…”
Get full text
Journal Article -
5
-
6
-
7
Polyglobulie de Vaquez : enfin un score pronostique ?
Published in Hématologie (01-11-2013)Get full text
Journal Article -
8
Appraisal of IgM Kappa/IgM Lambda Variations Using HevyLite® After Rituximab As Consolidation Therapy in Patients with Waldenström’s Macroglobulinemia
Published in Blood (16-11-2012)“…Abstract 4879 In Waldenström’s Macroglobulinemia (WM), response rates to rituximab (RTX) range from 30% to 75%. RTX is also known to generate a transient IgM…”
Get full text
Journal Article -
9
Appraisal of IgM Kappa/IgM Lambda Variations Using HevyLite® After Rituximab As Consolidation Therapy in Patients with Waldenström's Macroglobulinemia
Published in Blood (16-11-2012)“…Abstract 4879…”
Get full text
Journal Article -
10